Search research articles
Contact Us
Filters
Showing results (81-90 of 189) with videos related to
Page
of 19
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society
|
August 7, 2021
On-Demand Therapy for OFF Episodes in Parkinson's Disease
C Warren Olanow, Werner Poewe, Olivier Rascol, et al.
Archives of Neurology
|
June 16, 2005
Intermittent vs continuous levodopa administration in patients with advanced Parkinson disease: a clinical and pharmacokinetic study
Fabrizio Stocchi, Laura Vacca, Stefano Ruggieri, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
July 22, 2014
Peripheral alpha-synuclein and Parkinson's disease
C Warren Olanow, Dustin R Wakeman, Jeffrey H Kordower
Movement Disorders : Official Journal of the Movement Disorder Society
|
October 7, 2020
A New Approach to the Development of Disease-Modifying Therapies for PD; Fighting Another Pandemic
Karl Kieburtz, Russell Katz, Andrew McGarry, et al.
The Biochemical Journal
|
April 10, 2003
Activation of phosphoinositide 3-kinase by D2 receptor prevents apoptosis in dopaminergic cell lines
Venugopalan D Nair, C Warren Olanow, Stuart C Sealfon
Annals of Neurology
|
April 1, 2003
Neuroprotection for Parkinson's disease: prospects and promises
C Warren Olanow, Anthony H V Schapira, Yves Agid
Annals of Neurology
|
January 8, 2009
Why have we failed to achieve neuroprotection in Parkinson's disease?
C Warren Olanow, Karl Kieburtz, Anthony H V Schapira
The Journal of Pharmacology and Experimental Therapeutics
|
January 23, 2003
Levodopa is toxic to dopamine neurons in an in vitro but not an in vivo model of oxidative stress
Catherine Mytilineou, Ruth H Walker, Ruth JnoBaptiste, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
November 2, 2018
Adverse event reporting in clinical trials in Parkinson's Disease: Time for change
C Warren Olanow, Christopher Kenney, Stephen Bandak, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
June 5, 2003
Sleepiness in Parkinson's disease: a controlled study
Matthew A Brodsky, James Godbold, Tom Roth, et al.
Page
of 19
Search research articles
Search
Showing results (81-90 of 189) with videos related to
Sort By:
Page
of 19
Movement Disorders : Official Journal of the Movement Disorder Society
|
August 7, 2021
On-Demand Therapy for OFF Episodes in Parkinson's Disease
C Warren Olanow, Werner Poewe, Olivier Rascol, et al.
Archives of Neurology
|
June 16, 2005
Intermittent vs continuous levodopa administration in patients with advanced Parkinson disease: a clinical and pharmacokinetic study
Fabrizio Stocchi, Laura Vacca, Stefano Ruggieri, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
July 22, 2014
Peripheral alpha-synuclein and Parkinson's disease
C Warren Olanow, Dustin R Wakeman, Jeffrey H Kordower
Movement Disorders : Official Journal of the Movement Disorder Society
|
October 7, 2020
A New Approach to the Development of Disease-Modifying Therapies for PD; Fighting Another Pandemic
Karl Kieburtz, Russell Katz, Andrew McGarry, et al.
The Biochemical Journal
|
April 10, 2003
Activation of phosphoinositide 3-kinase by D2 receptor prevents apoptosis in dopaminergic cell lines
Venugopalan D Nair, C Warren Olanow, Stuart C Sealfon
Annals of Neurology
|
April 1, 2003
Neuroprotection for Parkinson's disease: prospects and promises
C Warren Olanow, Anthony H V Schapira, Yves Agid
Annals of Neurology
|
January 8, 2009
Why have we failed to achieve neuroprotection in Parkinson's disease?
C Warren Olanow, Karl Kieburtz, Anthony H V Schapira
The Journal of Pharmacology and Experimental Therapeutics
|
January 23, 2003
Levodopa is toxic to dopamine neurons in an in vitro but not an in vivo model of oxidative stress
Catherine Mytilineou, Ruth H Walker, Ruth JnoBaptiste, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
November 2, 2018
Adverse event reporting in clinical trials in Parkinson's Disease: Time for change
C Warren Olanow, Christopher Kenney, Stephen Bandak, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
June 5, 2003
Sleepiness in Parkinson's disease: a controlled study
Matthew A Brodsky, James Godbold, Tom Roth, et al.
Page
of 19